Status:

ACTIVE_NOT_RECRUITING

Gluten-free Diet in PSC and IBD

Lead Sponsor:

Institute for Clinical and Experimental Medicine

Collaborating Sponsors:

Czech Academy of Sciences

Conditions:

Primary Sclerosing Cholangitis

Ulcerative Colitis

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Primary sclerosing cholangitis (PSC) is a progressive disease of the biliary tree, which represents one of the most frequent indications for orthotopic liver transplantation (OLTx) in developed countr...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (for PSC group):
  • Established diagnosis of PSC (based on radiologic features, typical finding on MRCP or ERCP)
  • Age 18 - 65 years
  • ALP 1,5x higher than ULN
  • Signed informed consent
  • Exclusion Criteria (for PSC group):
  • Patients on gluten-free diet
  • Patients with coeliac disease or wheat allergy
  • Liver transplant recipients
  • PSC/AIH overlap syndrome
  • Other causes of liver disease
  • Radiologic or clinical signs of decompensated liver cirrhosis
  • Advanced liver cirrhosis (MELD score ˃ 15)
  • Recurrent acute cholangitis or cholangiogenic sepsis in past 3 months
  • Use of antibiotics in past 3 months
  • History of malignancy
  • Pregnant women
  • Not signed informed consent
  • Inclusion criteria (for UC group):
  • Ulcerative colitis diagnosed based on clinical, endoscopic and histological findings
  • Extension of affected colon \> 15cm
  • Mayo score 0-4
  • Signed informed consent
  • Exclusion criteria (for UC group):
  • CMV, Clostridium difficile enterocolitis in past 3 months
  • Use of antibiotics in past 3 months
  • Patients with coeliac disease or wheat allergy
  • Patients on gluten-free diet
  • Pregnant women
  • Not signed informed consent
  • Biologic therapy
  • Methotrexate
  • Prednison \> 10 mg
  • Not signed informed consent

Exclusion

    Key Trial Info

    Start Date :

    January 1 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2026

    Estimated Enrollment :

    60 Patients enrolled

    Trial Details

    Trial ID

    NCT06026449

    Start Date

    January 1 2023

    End Date

    December 31 2026

    Last Update

    January 8 2026

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Institute of clinical and experimental medicine

    Prague, Prague, Czechia, 14021

    Gluten-free Diet in PSC and IBD | DecenTrialz